Stay updated on Emactuzumab and Atezolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.

Latest updates to the Emactuzumab and Atezolizumab Combination Clinical Trial page
- Check7 days agoChange DetectedUI and metadata updates include showing the glossary, a standardized QC criterion label ('Last Update Submitted that Met QC Criteria'), and a new Revision: v3.4.0. Older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or replaced.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision label changed from v3.3.3 to v3.3.4, a minor technical update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study locations section was updated to include Connecticut, Massachusetts, New York, and Navarre, and the prior location blocks for these areas were removed; the page revision updated to v3.3.3.SummaryDifference0.5%

- Check65 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check72 days agoChange DetectedPublication descriptions were updated to indicate that PubMed entries are automatically filled in from PubMed and may not be about the study, and the revision tag was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe government funding status notice banner was removed; the study details page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Emactuzumab and Atezolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.